TNF and tuberculosis: However, the difference was not statistically significant, probably due to the small number of patients on this drug; however, an interesting—and statistically significant—finding regarding CZP therapy was that it was associated with the highest likelihood of TB development in the first year of exposure compared to the other TNF inhibitors agents.